Description
PT-141 + Oxytocin research spray
PT-141 + Oxytocin combines bremelanotide, a melanocortin receptor agonist, with oxytocin, a neurohypophyseal peptide hormone, in one spray solution.
Product details
| Compound | PT-141 (bremelanotide) and oxytocin |
|---|---|
| Class | Melanocortin agonist + neurohypophyseal peptide spray |
| Strength | 10ml / 100mcg per spray / 10mg |
| Labelling | Compound name and strength on every container |
Select your format and strength from the options above.
What PT-141 + Oxytocin research has examined
- PT-141: MC4R agonism in the CNS.
- Oxytocin: oxytocin receptor signalling.
- Combination research: neuropeptide pathways side by side.
Research interest does not establish a proven effect in humans.
Regulatory status
Licensed medicines containing this active ingredient are prescription-only products made by authorised manufacturers. The material sold here is a research chemical, not a licensed medicine, and is not approved for any use in humans.
Storage and handling
Store lyophilised vials cold, dry and away from light. Reconstitute with a suitable sterile diluent under aseptic conditions and keep solutions refrigerated. See our peptide reconstitution guide.
Related research products
Oxytocin Spray · Glow Blend Spray · Thymalin + Epithalon · All peptide sprays
References
For laboratory research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure or prevent any disease.
Reviews
There are no reviews yet.